Key result
PAAT correlates weakly with sPAP and fails as a reliable estimator in critically ill patients.
Why the study?
It was unknown whether PAAT correlates with sPAP in critically ill patients with and without right ventricular systolic dysfunction.
Does pulmonary artery acceleration time (PAAT) accurately correlate with systolic pulmonary artery pressure (sPAP) in critically ill patients with and without right ventricular systolic dysfunction?
Observational (n=236)
Blinded assessors
No
Does pulmonary artery acceleration time (PAAT) accurately correlate with systolic pulmonary artery pressure (sPAP) in critically ill patients with and without right ventricular systolic dysfunction?
Effect estimate: ρ -0.189
p-value: p=0.0035
PAAT is not a reliable surrogate for estimating systolic pulmonary artery pressure in critically ill cardiothoracic patients, particularly those with right ventricular systolic impairment.
PAAT should not guide sPAP estimation in critically ill patients; leaves open validation of superior noninvasive alternatives.
Background Estimation of pulmonary pressures is of key importance in acute cardiovascular and respiratory failure. Pulmonary artery acceleration time (PAAT) has emerged as reliable parameter for the estimation of systolic pulmonary artery pressure (sPAP) in cardiological population with preserved right ventricular function. We sought to find whether PAAT correlates with sPAP in critically ill patients with and without right ventricular (RV) systolic dysfunction. Methods Observational study . We measured sPAP using continuous-wave Doppler analysis of tricuspid regurgitation velocity peak method and we assessed the validity of PAAT in estimating sPAP in patients admitted to adult intensive care unit (ICU) for acute cardiovascular and respiratory failure. Results We enrolled 236 patients admitted to cardiothoracic ICU for cardiovascular and respiratory failure (respectively: 129, 54.7% and 107, 45.3%). 114 (48.3%) had preserved RV systolic function (defined as TAPSE ≥ 17 mm), whilst 122 (51.7%) had RV systolic impairment (defined as TAPSE < 17 mm). A weak inverse correlation between PAAT and sPAP (ρ–0.189, p 0.0035) was observed in overall population, which was confirmed in those with preserved RV systolic PAAT and sPAP (ρ–0.361, p 0.0001). In patients with impaired RV systolic function no statistically significant correlation between PAAT and sPAP was demonstrated ( p 0.2737). Adjusting PAAT values for log 10 , heart rate and RV ejection time did not modify the abovementioned correlations. Conclusions PAAT measurement to derive sPAP is not reliable in cardiothoracic critically ill patients, particularly in the coexistence of RV systolic impairment.
No takes yet. Share an insight, caveat, or question.
Dammassa et al. (2022) conducted an observational in Acute cardiovascular and respiratory failure (n=236). Pulmonary artery acceleration time (PAAT) vs. Tricuspid regurgitation velocity peak method (TRVmax) was evaluated on Correlation between PAAT and sPAP in the overall population (ρ -0.189, p=0.0035). Pulmonary artery acceleration time showed only a weak inverse correlation with systolic pulmonary artery pressure (ρ -0.189, p=0.0035), demonstrating it is not a reliable estimator in critically ill patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: